19
Analisis Kondisi Keuangan 1. Aspek Likuiditas LIKUIDITAS 2004 2005 2006 2007 Current ratio 3,0098 4,0450 5,0417 4,9825 Quick ratio 2,4396 2,8345 3,6988 3,0915 Cash ratio 0 , 6928 1,0159 1,9149 1,4793 Dari grafik diatas, dapat dilihat bahwa Current ratio dari tahun 2004 sampai tahun 2006 mengalami peningkatan namun pada tahun 2007 mengalami penurunan walaupun tidak signifikan. Quick ratio juga ada pada kondisi yang sama yaitu mengalami peningkatan pada tahun 2004 sampai tahun 2006, sedangkan pada tahun 2007 Quick ratio mengalami penurunan yang signifikan. Demikian pula dengan Cash ratio, terjadi peningkatan pada tahun 2004 sampai dengan 2006 dan penurunan yang signifikan 0 10.000 20.000 30.000 40.000 50.000 60.000 2004 2005 2006 2007 Axis Title Current ratio Quick ratio Cash ratio

Anlisis Keuangan PT. Kalbe Farma Tbk

Embed Size (px)

Citation preview

Page 1: Anlisis Keuangan PT. Kalbe Farma Tbk

Analisis Kondisi Keuangan

1. Aspek Likuiditas

LIKUIDITAS 2004 2005 2006 2007

Current ratio 3,0098 4,0450 5,0417 4,9825

Quick ratio 2,4396 2,8345 3,6988 3,0915

Cash ratio 0,6928 1,0159 1,9149 1,4793

Dari grafik diatas, dapat dilihat bahwa Current ratio dari tahun 2004 sampai tahun 2006

mengalami peningkatan namun pada tahun 2007 mengalami penurunan walaupun tidak

signifikan. Quick ratio juga ada pada kondisi yang sama yaitu mengalami peningkatan pada

tahun 2004 sampai tahun 2006, sedangkan pada tahun 2007 Quick ratio mengalami

penurunan yang signifikan. Demikian pula dengan Cash ratio, terjadi peningkatan pada tahun

2004 sampai dengan 2006 dan penurunan yang signifikan

0

10.000

20.000

30.000

40.000

50.000

60.000

2004 2005 2006 2007

Axi

s Ti

tle

Current ratio

Quick ratio

Cash ratio

Page 2: Anlisis Keuangan PT. Kalbe Farma Tbk

2. Aspek Leverage

2004 2005 2006 2007 Debt Ratio 50,95% 38,52% 23,35% 21,82%

Equity Ratio 4,01% 50,52% 64,75% 65,91% Debt Equity

Ratio 126,09% 76,24% 36,06% 33,10%

Debt asset pada tahun 2004 sampai tahun 2006 mengalami penurunan yang signifikan

sedangkan untuk tahun 2007 relatif stabil. Untuk Equity ratio mengalami penurunan

yang tidak begitu besar dari tahun 2004 sampai tahun 2006 sedangkan untuk tahun

2007 masih relatif stabil.

3. Aspek Efisiensi

EFISIENSI 2004 2005 2006 2007

Average Collection Period 148,755 134,7335 143,990 163,1268

Account Receivables Turnover 0,0067 0,0074 0,0069 0,00613

Total Asset Turnover 0,296 0,3274 0,352 0,3734

0%10%20%30%40%50%60%70%80%90%

100%110%120%130%

2004 2005 2006 2007

Debt Ratio

Equity Ratio

Debt Equity Ratio

Page 3: Anlisis Keuangan PT. Kalbe Farma Tbk

Inventory Turnover 33,827 5,21668 36,9395 29,628

Fixed Asset Turnover 1,805 1,802 1,5919 1,593

Fixed asset turnover dari tahun 2004 mengalami peningkatan yang signifikan,namun dari

tahun 2005 menuju 2007 mengalami penurunan yang juga signifikan. Inventory turnover dan

Account receivables turnover mengalami kondisi yang hampir sama dengan Fixed asset

turnover. Hanya total asset turnover yang hamper tiap tahun mengalami peningkatan

walaupun tidak terlalu signifikan.

4. Aspek Profitabilitas

Operating

profit margin net profit margin

operating income return on investment

return on equity

return on asset

2004 19.11 10.9 21.62 30.53 21.62 2005 18.08 11.12 22.45 27.34 22.45 2006 1.76 11.14 23.57 22.59 23.57 2007 16.12 10.07 22.55 22.59 22.55

0.0000

100.0000

200.0000

300.0000

400.0000

500.0000

600.0000

700.0000

2004 2005 2006 2007

Fixed AssetTurnover

Inventory Turnover

Total AssetTurnover

AccountReceivablesTurnoverAverageCollection Period

Page 4: Anlisis Keuangan PT. Kalbe Farma Tbk

Operating profit margin dari tahun 2004 ke tahun 2006 mengalami penurunan,peningkatan

terjadi pada tahun 2007 .Net profit margin ,Return on assets (ROA) , dan operating income

return on investment mengalami peningkatan dari tahun 2004 sampai tahun 2006 dan

mengalami penurunan pada tahun 2007 walaupun dalam jumlah yang tidak signifikan.

grafik profitabilitas

05

1015

20253035

2004 2005 2006 2007

tahun

nila

i (%

)operating profit margin

net profit margin

operating income returnon investmentreturn on equity

return on asset

earning per share

0

20

40

60

80

100

120

2004 2005 2006 2007

tahun

nila

i (R

p)

earning per share

earning per share 2004 45.845 2005 64.329 2006 66.6188 2007 111.2005

Page 5: Anlisis Keuangan PT. Kalbe Farma Tbk

time interest earned

ratio 2004 9.9648 2005 11.8988 2006 15.189 2007 20.0401

Time interest earned ratio dan earnings per share (EPS) mengalami pertumbuhan yang positif

dari tahun ke tahun.

time interest earned ratio

0

5

10

15

20

25

2004 2005 2006 2007

tahun

nila

i (ka

li)

time interest earned ratio

Page 6: Anlisis Keuangan PT. Kalbe Farma Tbk

Analisis Hubungan dan Pengaruh Kondisi Keuangan terhadap Harga Saham

Perusahaan

Grafik Harga Saham PT Kalbe Farma Tbk

Grafik.1

Grafik 2

Dilihat dari grafik 2 pertumbuhan antara harga saham dari nilai open (pembukaan),high

(tinggi), low(rendah), dan close (penutupan) relatif sama. Awal tahun 2004 sampai tahun

akhir tahun 2005 peningkatan dan penurunan harga yang terjadi relatif stabil.

0.005,000,000.00

10,000,000.0015,000,000.0020,000,000.0025,000,000.0030,000,000.0035,000,000.0040,000,000.0045,000,000.00

Jan-

04

Apr-0

4

Jul-0

4

Oct

-04

Jan-

05

Apr-0

5

Jul-0

5

Oct

-05

Jan-

06

Apr-0

6

Jul-0

6

Oct

-06

Jan-

07

Apr-0

7

Jul-0

7

Oct

-07

OpenHighLowCloseAvg Vol

0.00200.00400.00600.00800.00

1,000.001,200.001,400.001,600.001,800.00

Jan-

04

Apr-0

4

Jul-0

4

Oct

-04

Jan-

05

Apr-0

5

Jul-0

5

Oct

-05

Jan-

06

Apr-0

6

Jul-0

6

Oct

-06

Jan-

07

Apr-0

7

Jul-0

7

Oct

-07

OpenHighLowClose

Page 7: Anlisis Keuangan PT. Kalbe Farma Tbk

Nilai open atau pembukaan mengalami pertumbuhan yang signifikan pada bulan Januari

2006 sampai dengan bulan April 2006. Titik tertinggi dari data saham pada nilai open yaitu

titik 1520,00 pada bulan Maret 2006, sedangkan titik terendah pada nilai open berada pada

titik 364,00 pada bulan Juli 2004.

Dari nilai high atau tinggi, pertumbuhan yang stabil dimulai pada bulan Desember 2005

dengan diawali peningkatan yang signifikan sebesar 430,00 dari bulan sebelumnya. Titik

tertinggi harga saham pada nilai high yaitu pada titik 1570,00 pada bulan April 2006.

Nilai low atau rendah mengalami peningkatan yang signifikan pada akhir tahun 2005. Namun

pada bulan berikutnya di tahun 2006 nilai low atau rendah mengalami penurunan yang

signifikan yaitu sebesar 240,00 00 (dari nilai 1330,00 pada bulan April 2006 turun menjadi

1090,00 di bulan Mei pada tahun yang sama). Titik terendah pada nilai low atau rendah

berada bulan Mei dan Juni 2004 yaitu di titik 350,00.

Nilai close atau penutupan mengalami pertumbuhan yang relatif lebih stabil bila

dibandingkan nilai-nilai yang lain. Peningkatan yang signifikan terjadi pada bulan Januari

2006 yaitu di titik 1300,00 dan penurunan signifikan terjadi pada bulan Mei 2006 yaitu titik

1320,00. Titik tertinggi pada nilai close terjadi pada bulan Februari 2006 yaitu titik 1520,00.

Page 8: Anlisis Keuangan PT. Kalbe Farma Tbk

LAMPIRAN

Perhitungan Rasio Keuangan

1. Aspek Likuiditas

Tahun 2004

Current ratio = Total current assets = 2.355.453.119.543 = 3,0098 kali

Total current liabilities 782.589.561.271

Quick ratio = Current assets – inventories = 2.355.453.119.543 – 446.229.261.434

Current liabilities 782.589.561.271

= 2,4396 kali

Cash ratio = Cash + Marketable Securities = 524.225.511.866 + 0 = 0,6928 kali

Current liabilities 782.589.561.271

Tahun 2005

Current ratio = Total current assets = 3.654.805.881.213 = 4,0450 kali

Total current liabilities 903.515.824.098

Quick ratio = Current assets – inventories = 3.654.805.881.213 – 1.093.722.204.050

Current liabilities 903.515.824.098

= 2,8345 kali

Cash ratio = Cash + Marketable Securities = 917.902.597.501 + 0 = 1,0159 kali

Current liabilities 903.515.824.098

Tahun 2006

Current ratio = Total current assets = 3.321.278.260.845 = 5,0417 kali

Total current liabilities 658.759.610.990

Quick ratio = Current assets – inventories = 3.321.278.260.845 – 884.654.354.165

Current liabilities 658.759.610.990

Page 9: Anlisis Keuangan PT. Kalbe Farma Tbk

= 3,6988 kali

Cash ratio = Cash + Marketable Securities = 1.261.454.016.042 + 0 = 1,9149 kali

Current liabilities 658.759.610.990

Tahun 2007

Current ratio = Total current assets = 3.760.007.626.324 = 4,9825 kali

Total current liabilities 754.629.114.054

Quick ratio = Current assets – inventories

Current liabilities

= 3.760.007.626.324 – 1.427.067.984.707

754.629.114.054

= 3,0915 kali

Cash ratio = Cash + Marketable Securities = 1.116.346.134.197 + 0 = 1,4793 kali

Current liabilities 754.629.114.054

2. Aspek Leverage

Tahun 2004

Total Debt to Equity = 1.537.379.862.592 / 1.219.193.365.029

= 1, 2609

Total Debt Ratio = 1.537.379.862..592 / 3. 016.864.058.832

= 0,5095

Total Equity Ratio = 1.219.193.365.029 / 3.016.864.058.832

= 0, 0401

Page 10: Anlisis Keuangan PT. Kalbe Farma Tbk

Tahun 2005

Total Debt to Equity = 1.821.583.815.287 / 2.389.006.139.774

= 0,7624

Total Debt Ratio = 1.821.583.815.287 / 4. 728.368.509.889

= 0,3852

Total Equity Ratio = 2.389.006.139.774 / 4. 728.368.509.889

= 0, 5052

2006

Total Debt to Equity = 1.080.170.510.233 / 2.994.816.751.748

= 0, 3606

Total Debt Ratio = 1.080.170.510.233 / 4.624.619.204.478

= 0, 2335

Total Equity Ratio = 2.994.816.751.748 / 4.624.619.204.478

= 0, 6475

2007

Total Debt to Equity = 1.121.188.133.752 / 3.386.861.941.228

= 0,3310

Total Debt Ratio = 1.121.188.133.752 / 5.138.212.506.980

= 0,2182

Total Equity Ratio = 3.386.861.941.228 / 5.138.212.506.980

= 0,6591

Page 11: Anlisis Keuangan PT. Kalbe Farma Tbk

3. Aspek Efisiensi

Tahun 2004

Average Collection Period = Accounts receivable = 517.538.017.729 .

Sales/360 1.252.483.148.923/360

= 517.538.017.729

3.479.119.856

= 148,755 hari

Total Asset Turnover = Sales = 1.252.483.148.923 = 0,296 kali

Total assets 4.231.054.215.67

Accounts Receiveable Turnover = Credit sales = 3.479.119.856

Accounts receivable 517.538.017.729

= 0.006722 kali

Inventory Turnover = Cost of Good Sold = 2.594.106.408.677

Inventory (34.525.749.482+42.159.610.714) / 2

= 33,827 kali

Fixed Asset Turnover = Sales = 1.252.483.148.923 = 1,805 kali

Fixed Asset 693.891.151.39

Tahun 2005

Average Collection Period = Accounts receivable = 579.456.506.285 .

Sales/360 1.548.272.703.156/360

= 579.456.506.285

4.300.757.508

= 134,7335 hari

Page 12: Anlisis Keuangan PT. Kalbe Farma Tbk

Total Asset Turnover = Sales = 1.548.272.703.156 = 0,32744 kali

Total assets 4.728.368.509.889

Accounts Receiveable Turnover = Credit sales = 4.300.757.508

Accounts receivable 579.456.506.285

= 0,007422 kali

Inventory Turnover = Cost of Good Sold = 2.861.338.378.048

Inventory (579.456.506.285+ 517.538.017.729) / 2

= 5,21668 kali

Fixed Asset Turnover = Sales = 1.548.272.703.156 = 1,802 kali

Fixed Asset 859.117.129.272

Tahun 2006

Average Collection Period = Accounts receivable = 652.272.015.649

Sales/360 1.630.792.432.129/360

= 652.272.015.649

4.529.978.978

= 143,990 hari

Total Asset Turnover = Sales = 1.630.792.432.129 = 0,352 kali

Total asset 4.624.619.204.478

Accounts Receiveable Turnover = Credit sales = 4.529.978.978

Accounts receivable 652.272.015.649

Page 13: Anlisis Keuangan PT. Kalbe Farma Tbk

= 0,006944 kali

Inventory Turnover = Cost of Good Sold = 2.972.908.038.954

Inventory (108.103.347.457+52.857.397.965) / 2

= 36,9395 kali

Fixed Asset Turnover = Sales = 1.630.792.432.129= 1,5919 kali

Fixed Asset 1.024.371.537.180

Tahun 2007

Average Collection Period = Accounts receivable = 869.572.349.473

Sales/360 1.919.034.803.322 / 360

= 869.572.349.473

5.330.652.231

= 163,1268 hari

Total Asset Turnover = Sales = 1.919.034.803.322 = 0,3734 kali

Total assets 5.138.212.506.980

Accounts Receiveable Turnover = Credit sales = 5.330.652.231

Accounts receivable 869.572.349.473

= 0,00613 kali

Inventory Turnover = Cost of Good Sold = 2.453.279.199.660

Inventory (57.501.290.031+108.103.347.457) / 2

= 29,628 kali

Fixed Asset Turnover = Sales = 1.919.034.803.322 = 1,593 kali

Fixed Asset 1.204.147.773.194

Page 14: Anlisis Keuangan PT. Kalbe Farma Tbk

4. Aspek Profitabilitas

Tahun 2004

Operating Income Return on Investment = Operating Income = 652.280.954.708

Total assets 3.016.864.058.832

= 0,2162%

Operating Profit Margin = Operating Income = 652.280.954.708 = 0,1911%

Sales 3.413.097.280.247

Net Profit Margin = Net Income = 372.335.218.425= 0,1090%

Sales 3.413.097.280.247

Times Interest Earned Ratio = Operating Income = 733.588.774.605 = 9,9648 kali

Interest Expense 73.617.289.483

Return on Equity = Net Income = 372.335.218.425 = 0,30539%

Common equity 1.219.193.365.029

Return on Asset = EBIT = = 652.280.954.708 = 0.2162 %

Total assets 3.016.864.058.832

Earning per shares = Net Income = 372.335.218.425 = 45,8450%

Share Outstanding 8.121.600.000

Page 15: Anlisis Keuangan PT. Kalbe Farma Tbk

Tahun 2005

Operating Income Return on Investment = Operating Income = 1.061.851.753.517

Total assets 4.728.368.509.880

= 0,2245%

Operating Profit Margin = Operating Income = 1.061.851.753.517 = 0,1808%

Sales 5.870.938.590.836

Net Profit Margin = Net Income = 653.329.339.498= 0,1112%

Sales 5.870.938.590.836

Times Interest Earned Ratio = Operating Income = 1.106.300.745.333 = 11,8988 kali

Interest Expense 92.975.053.874

Return on Equity = Net Income = 653.329.399.498 = 0,2734%

Common equity 2.389.006.139.774

Return on Asset = EBIT = 1.061.851.753.517

Total assets 4.728.368.509.880 = 0,2245%

Earning per shares = Net Income = 653.329.399.498 = 64,329%

Share Outstanding 10.156.014.422

Page 16: Anlisis Keuangan PT. Kalbe Farma Tbk

Tahun 2006

Operating Income Return on Investment = Operating Income = 1.090.081.383.436

Total assets 5.870.938.590.836

= 0,2357%

Operating Profit Margin = Operating Income = 1.071.271.451.115 = 0,0176%

Sales 6.071.550.437.967

Net Profit Margin = Net Income = 676.581.653.872= 0,1114%

Sales 6.071.550.437.96

Times Interest Earned Ratio = Operating Income = 1.071.271.451.115 = 15,1890 kali

Interest Expense 70.529.166.485

Return on Equity = Net Income = 676.581.653.872 = 0,2259%

Common equity 2.994.816.751.748

Return on Asset = EBIT = 1.090.081.383.436 = 0,2357%

Total assets 5.870.938.590.836

Earning per shares = Net Income = 676.581.653.872 = 66,6188%

Share Outstanding 10.156.014.422

Page 17: Anlisis Keuangan PT. Kalbe Farma Tbk

Tahun 2007

Operating Income Return on Investment = Operating Income = 1.158.667.237.090

Total assets 5.138.212.506.980

= 0,2255%

Operating Profit Margin = Operating Income = 1.129.354.542.486 = 0,1612%

Sales 7.004.909.851,908

Net Profit Margin = Net Income = 705.694.196.679= 0,1007%

Sales 7.004.909.851.908

Times Interest Earned Ratio = Operating Income = 1.129.354.542.486 = 20,0401 kali

Interest Expense 56.354.715.106

Return on Equity = Net Income = 705.694.196.679 = 0,2259%

Common equity 3.386.861.941.228

Return on Asset = EBIT = 1.158.667.237.090 = 0,2255%

Total assets 5.138.212.506.980

Earning per shares = Net Income = 1.129.354.542.486 = 111,2005%

Share Outstanding 10.156.014.422

Page 18: Anlisis Keuangan PT. Kalbe Farma Tbk

Daftar Harga Saham Bulanan PT Kalbe Farma Tbk

Date Open High Low Close Avg Vol Adj Close*

Dec-07 1,220.00 1,320.00 1,180.00 1,260.00 8,367,400 1,244.25

Nov-07 1,380.00 1,380.00 1,190.00 1,220.00 14,232,000 1,204.75

Oct-07 1,340.00 1,420.00 1,320.00 1,360.00 16,447,200 1,343.00

Sep-07 1,360.00 1,390.00 1,280.00 1,330.00 10,134,400 1,313.38

Aug-07 1,480.00 1,480.00 1,150.00 1,360.00 11,528,100 1,343.00

Jul-07 1,380.00 1,490.00 1,340.00 1,490.00 11,856,100 1,471.38

15-Jun-07 $ 10.00 Dividend

Jun-07 1,240.00 1,430.00 1,220.00 1,390.00 25,903,100 1,372.62

May-07 1,260.00 1,260.00 1,210.00 1,240.00 14,875,100 1,214.54

Apr-07 1,210.00 1,300.00 1,210.00 1,260.00 17,050,200 1,234.13

Mar-07 1,210.00 1,280.00 1,160.00 1,210.00 26,557,500 1,185.16

Feb-07 1,310.00 1,370.00 1,150.00 1,220.00 17,341,600 1,194.96

Jan-07 1,200.00 1,380.00 1,190.00 1,300.00 39,892,200 1,273.31

Dec-06 1,180.00 1,250.00 1,130.00 1,190.00 22,807,600 1,165.57

Nov-06 1,360.00 1,360.00 1,170.00 1,180.00 29,711,400 1,155.78

Oct-06 1,320.00 1,370.00 1,290.00 1,360.00 15,408,100 1,332.08

Sep-06 1,120.00 1,350.00 1,120.00 1,320.00 22,396,100 1,292.90

Aug-06 1,190.00 1,200.00 1,120.00 1,120.00 19,314,800 1,097.01

Jul-06 1,250.00 1,270.00 1,110.00 1,200.00 11,544,600 1,175.37

Jun-06 1,330.00 1,350.00 1,180.00 1,250.00 11,807,500 1,224.34

May-06 1,520.00 1,550.00 1,090.00 1,310.00 33,050,000 1,283.11

Apr-06 1,360.00 1,570.00 1,330.00 1,520.00 42,715,100 1,488.80

Mar-06 1,350.00 1,410.00 1,320.00 1,360.00 18,480,600 1,332.08

Feb-06 1,300.00 1,430.00 1,270.00 1,360.00 22,634,700 1,332.08

Jan-06 990.00 1,310.00 970.00 1,300.00 25,790,200 1,273.31

Dec-05 580.00 1,020.00 570.00 990.00 7,040,200 969.68

Nov-05 570.00 590.00 480.00 580.00 614,400 568.09

Oct-05 600.00 620.00 550.00 570.00 286,900 558.30

Sep-05 620.00 630.00 560.00 620.00 755,200 607.27

11-Aug-05 $ 5.00 Dividend

Aug-05 700.00 730.00 580.00 640.00 2,714,800 626.86

Jul-05 710.00 730.00 680.00 700.00 987,400 680.73

Jun-05 730.00 830.00 710.00 710.00 2,987,800 690.46

May-05 680.00 730.00 630.00 720.00 479,100 700.18

Apr-05 690.00 760.00 670.00 670.00 2,891,200 651.56

Page 19: Anlisis Keuangan PT. Kalbe Farma Tbk

Mar-05 700.00 760.00 650.00 680.00 5,356,300 661.28

Feb-05 570.00 870.00 530.00 700.00 7,516,900 680.73

Jan-05 530.00 620.00 530.00 580.00 2,832,800 564.04

Dec-04 525.00 575.00 500.00 550.00 1,925,900 534.86

Nov-04 450.00 575.00 450.00 550.00 5,393,000 534.86

Oct-04 415.00 480.00 415.00 450.00 8,723,400 437.61

Sep-04 405.00 430.00 385.00 410.00 4,669,400 398.71

12-Aug-04 $ 10.00 Dividend

Aug-04 405.00 415.00 375.00 405.00 2,624,800 393.85

Jul-04 365.00 440.00 360.00 405.00 7,191,900 383.88

Jun-04 400.00 405.00 350.00 360.00 1,217,000 341.23

May-04 500.00 525.00 350.00 410.00 4,310,600 388.62

Apr-04 475.00 625.00 475.00 500.00 2,334,400 473.93

Mar-04 500.00 525.00 460.00 470.00 2,161,700 445.49

Feb-04 490.00 575.00 480.00 525.00 3,393,500 497.62

Jan-04 370.00 525.00 370.00 490.00 9,493,000 464.45

* Close price adjusted for dividends and splits.